Natrol
This article was originally published in The Tan Sheet
Executive Summary
Remedief pain management supplement launching in food, drug and mass outlets nationwide in September, positioned on OTC shelves to compete with pain relievers such as Tylenol and Advil, firm announces June 22. Product contains 160 mg white willow, 100 mg kava, 75 mg boswellia and 75 mg Nexrutine, a proprietary COX-II inhibitor manufactured by Irvine, Calif.-based Next Pharmaceuticals. Remedief delivers "natural relief of pain associated with tension, stress and overexertion," Natrol says. Directions advise one-a-day dose and suggest consumers not take more than five capsules in 24 hours; 20 capsules carry a suggested retail price of $6.99. Print ads slated to debut in late September
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning